LUCY Stock Price, Innovative Eyewear, Inc. Quote, Chart

Market Summary

USD0.19-0.01

Delayed

-5.00%

LUCY Stock Price

View Fullscreen

LUCY RSI Chart

LUCY Valuation

Market Cap

3.3M

Price/Earnings (Trailing)

-0.46

Price/Sales (Trailing)

2.39

Price/Free Cashflow

-0.56

LUCY Price/Sales (Trailing)

LUCY Profitability

Operating Margin

-8.82%

Return on Equity

-184.64%

Return on Assets

-149.68%

Free Cashflow Yield

-177.11%

LUCY Fundamentals

LUCY Revenue

Revenue (TTM)

1.4M

Rev. Growth (Yr)

164.61%

Rev. Growth (Qtr)

-37.72%

LUCY Earnings

Earnings (TTM)

-7.2M

Earnings Growth (Yr)

-37.78%

Earnings Growth (Qtr)

17.65%

Breaking Down LUCY Revenue

Last 7 days

-5%

Last 30 days

-26.9%

Last 90 days

-54.8%

How does LUCY drawdown profile look like?

LUCY Financial Health

Current Ratio

4.65

LUCY Investor Care

Shares Dilution (1Y)

107.92%

Diluted EPS (TTM)

-0.6

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.4M	0	0	0
2023	568.7K	533.9K	603.8K	1.2M
2022	682.9K	675.2K	667.5K	659.8K
2021	0	0	0	690.7K

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold LUCY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	MORGAN STANLEY	unchanged	-	-537	984	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	unchanged	-	-37.00	68.00	-%
May 15, 2024	SABBY MANAGEMENT, LLC	new	-	5,242,000	5,242,000	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	0.89	-1,224	2,299	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	new	-	7,976	7,976	-%
May 15, 2024	Hudson Bay Capital Management LP	unchanged	-	3,879	9,982	-%
May 15, 2024	CITADEL ADVISORS LLC	added	1.91	1,297	3,249	-%
May 15, 2024	CITADEL ADVISORS LLC	new	-	10,888	10,888	-%
May 13, 2024	UBS Group AG	sold off	-100	-4,458	-	-%
May 13, 2024	CLEAR STREET LLC	reduced	-0.06	6,000	15,000	-%

Are Funds Buying or Selling LUCY?

Are funds buying LUCY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LUCY

No. of Funds

Unveiling Innovative Eyewear, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 09, 2024	intracoastal capital, llc	5.9%	1,037,600	SC 13G

Recent SEC filings of Innovative Eyewear, Inc.

View All Filings

Date Filed	Form Type	Document
May 17, 2024	PRE 14A	PRE 14A
May 14, 2024	10-Q	Quarterly Report
May 09, 2024	SC 13G	Major Ownership Report
May 03, 2024	424B5	Prospectus Filed
May 01, 2024	8-K	Current Report
May 01, 2024	424B5	Prospectus Filed
Apr 29, 2024	8-K	Current Report
Apr 16, 2024	8-K	Current Report
Apr 15, 2024	424B5	Prospectus Filed
Mar 29, 2024	EFFECT	EFFECT

Peers (Alternatives to Innovative Eyewear, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Innovative Eyewear, Inc. News

Latest updates

Innovative Eyewear, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)												(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2
Revenue	-37.7%	383	616	222	170	145	67.00	152	205	236	204	171	127
Cost Of Revenue	-52.7%	377	796	142	200	135	264	129	161	162	-	130	94.00
Gross Profit	103.9%	7.00	-180	80.00	-29.82	10.00	-196	23.00	43.00	74.00	-	41.00	33.00
Operating Expenses	-12.7%	2,022	2,315	1,677	1,304	1,439	1,680	1,389	1,190	1,263	-	1,132	550
S&GA Expenses	-42.5%	661	1,150	534	104	259	513	569	392	585	-	513	271
R&D Expenses	79.0%	216	121	193	197	151	132	305	53.00	36.00	-	9.00	19.00
Interest Expenses	-	-	-	-	1.00	2.00	4.00	38.00	45.00	18.00	-	10.00	15.00
Net Income	17.6%	-1,971	-2,393	-1,551	-1,287	-1,430	-1,877	-1,404	-1,193	-1,206	-1,385	-1,100	-536
Net Income Margin	10.4%	-5.18*	-5.78*	-10.18*	-11.24*	-10.39*	-8.61*	-7.78*	-7.24*	-6.19*	-4.70*	-	-
Free Cashflow	-35.1%	-1,499	-1,109	-1,429	-1,850	-1,455	-1,148	-1,020	-513	-662	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet									(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2021Q4
Assets	-22.6%	4,813	6,219	8,116	9,340	5,113	4,690	6,418	1,101	824
Current Assets	-26.8%	4,111	5,617	7,501	8,770	4,542	4,241	6,102	835	644
Cash Equivalents	-38.2%	2,649	4,287	3,904	5,356	3,450	3,591	4,976	35.00	80.00
Inventory	61.1%	859	533	776	660	743	95.00	423	325	276
Net PPE	8.0%	143	133	178	125	138	120	98.00	53.00	20.00
Liabilities	38.1%	911	660	474	389	563	665	851	2,453	617
Current Liabilities	41.5%	883	624	431	331	505	600	851	2,453	617
LT Debt, Current	-	-	-	-	-	-	61.00	166	1,938	289
Shareholder's Equity	-29.8%	3,902	5,559	7,642	8,951	4,550	4,024	5,567	-	208
Retained Earnings	-11.6%	-18,940	-16,969	-14,575	-13,024	-11,736	-10,305	-8,428	-7,024	-4,624
Additional Paid-In Capital	1.4%	22,842	22,528	22,218	21,976	16,287	14,330	14,000	5,677	4,843
Shares Outstanding	0.1%	12,934	12,917	12,917	12,917	7,716	7,307	6,673	6,060	6,060
Float	-	-	-	-	6,917	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)												(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2
Cashflow From Operations	-29.2%	-1,467	-1,135	-1,359	-1,843	-1,427	-1,117	-970	-505	-630	-	-	-
Share Based Compensation	-25.2%	232	310	242	-40.18	424	335	305	417	417	-	-	-
Cashflow From Investing	-104.8%	-95.54	2,010	-93.42	-1,978	-136	-64.52	-57.67	-15.09	-82.66	-	-	-
Cashflow From Financing	84.5%	-75.99	-490	-	5,729	1,423	-203	5,970	513	676	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LUCY Income Statement

2024-03-31

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues, net	$ 383,471	$ 144,921
Less: Cost of Goods Sold	(376,520)	(134,630)
Gross Profit	6,951	10,291
Operating Expenses:
General and administrative	(1,108,946)	(993,772)
Sales and marketing	(661,295)	(259,297)
Research and development	(216,301)	(151,169)
Related party management fee	(35,000)	(35,000)
Total Operating Expenses	(2,021,542)	(1,439,238)
Other Income (Expense)	43,280	76
Interest Expense		(1,939)
Total Other Income (Expense), net	43,280	(1,863)
Net Loss	$ (1,971,311)	$ (1,430,810)
Weighted average number of shares outstanding, basic	12,952,106	7,569,115
Weighted average number of shares outstanding, diluted	12,952,106	7,569,115
Loss per share, basic	$ (0.15)	$ (0.19)
Loss per share, diluted	$ (0.15)	$ (0.19)

LUCY Balance Sheet

2024-03-31

CONDENSED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 2,648,566	$ 4,287,447
Accounts receivable, net of allowances of $21,437 and $25,772, respectively	52,779	93,211
Prepaid expenses	425,867	313,648
Inventory prepayment	59,407	323,520
Inventory	858,905	533,239
Due from Tekcapital and Affiliates	5,830	6,256
Other current assets	59,447	59,447
Total Current Assets	4,110,801	5,616,768
Non-Current Assets
Patent costs, net	330,192	286,429
Capitalized software costs	110,073	110,073
Property and equipment, net	143,487	132,848
Other non-current assets	118,458	72,644
TOTAL ASSETS	4,813,011	6,218,762
Current Liabilities
Accounts payable and accrued expenses	840,992	581,986
Deferred revenue	42,500	42,500
Total Current Liabilities	883,492	624,486
Non-Current Liabilities
Deferred revenue	27,950	35,450
TOTAL LIABILITIES	911,442	659,936
Commitments and contingencies (Note 7)
Stockholders’ Equity
Common stock (par value $0.00001, 50,000,000 shares authorized, and 13,233,544 and 12,917,239 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively)	132	129
Additional paid-in capital	22,842,163	22,528,112
Accumulated deficit	(18,940,726)	(16,969,415)
TOTAL STOCKHOLDERS’ EQUITY	3,901,569	5,558,826
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 4,813,011	$ 6,218,762

About Innovative Eyewear, Inc.

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

CEO	Mr. Harrison Reed Gross
WEBSITE	lucyd.co
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	9

Innovative Eyewear, Inc. Frequently Asked Questions

What is the ticker symbol for Innovative Eyewear, Inc.? What does LUCY stand for in stocks?

LUCY is the stock ticker symbol of Innovative Eyewear, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Innovative Eyewear, Inc. (LUCY)?

As of Fri May 17 2024, market cap of Innovative Eyewear, Inc. is 3.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LUCY stock?

You can check LUCY's fair value in chart for subscribers.

What is the fair value of LUCY stock?

You can check LUCY's fair value in chart for subscribers. The fair value of Innovative Eyewear, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Innovative Eyewear, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LUCY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Innovative Eyewear, Inc. a good stock to buy?

The fair value guage provides a quick view whether LUCY is over valued or under valued. Whether Innovative Eyewear, Inc. is cheap or expensive depends on the assumptions which impact Innovative Eyewear, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LUCY.

What is Innovative Eyewear, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, LUCY's PE ratio (Price to Earnings) is -0.46 and Price to Sales (PS) ratio is 2.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LUCY PE ratio will change depending on the future growth rate expectations of investors.